megestrol acetate has been researched along with Local Neoplasm Recurrence in 40 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (17.50) | 18.7374 |
| 1990's | 6 (15.00) | 18.2507 |
| 2000's | 10 (25.00) | 29.6817 |
| 2010's | 12 (30.00) | 24.3611 |
| 2020's | 5 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Ascione, M; Bifulco, G; Boccia, D; Buonfantino, C; Cafasso, V; De Angelis, MC; Della Corte, L; Giampaolino, P; Grasso, G; Gullo, G; Mercorio, A; Palumbo, M; Serafino, P; Verrazzo, P; Viciglione, F | 1 |
| Forget, AN; Kulkarni, A; Mallick, R; Ramsay, T; Weberpals, JI; Wright, NMA | 1 |
| Chung, YS; Kim, S; Kim, SW; Kim, YT; Lee, JY; Nam, EJ; Park, E; Woo, HY | 1 |
| He, Y; Wang, J; Wang, Y; Zhou, R | 1 |
| Cho, A; Kim, DY; Kim, JH; Kim, YM; Kim, YT; Lee, SW; Park, JY; Suh, DS | 1 |
| Choi, YM; Kim, H; Kim, SH; Kim, SW; Ku, SY; Suh, CS | 1 |
| Basaran, D; Boran, N; Comert, GK; Kar, I; Karalok, A; Kilic, C; Turan, T; Turkmen, O; Yucel, O | 1 |
| Jiang, ZX; Ju, XZ; Ren, YL; Shan, BE; Sun, JM; Tu, XY; Wang, HY; Zang, RY | 1 |
| Bing, S; Lijuan, D; Santai, S; Shaohua, Z; Shikai, W; Tao, W; Xiangying, M; Xin, Z; Yan, M; Yue, W; Zefei, J | 1 |
| Bae, DS; Kim, DY; Kim, JH; Kim, JW; Kim, TJ; Kim, YM; Kim, YT; Nam, JH; Park, JY | 1 |
| Burke, JJ; Davidson, SA; Downey, G; Filiaci, VL; Fleming, GF; Hanjani, P; Leslie, KK; Makker, V; Marzullo, B; Pearl, M; Reyes, HD; Van Le, L; Walker, JL; Zaino, RJ; Zweizig, SL | 1 |
| Bi, Y; Chen, M; Jin, Y; Li, Y; Pan, L; Shan, Y | 1 |
| Cetinkaya, N; Erkaya, S; Gungor, T; Yalcin, H; Zergeroglu, S | 1 |
| Chetaille, E; Geniaux, A; Green, JA; Hall, G; Joly, F; Kutarska, E; Lisyanskaya, A; Melichar, B; Oaknin, A; Ostapenko, V; Pautier, P; Reed, N; Shoaib, M; Vergote, I; Zvirbule, Z | 1 |
| Couluris, M; Freyer, DR; Krischer, JP; Mayer, JL; Sandler, E; Xu, P | 1 |
| Kim, JY; Park, CT; Park, H; Seok, JM; Seong, SJ; Shim, JY; Yoon, BS | 1 |
| Bae, DS; Kim, DY; Kim, JH; Kim, JW; Kim, KR; Kim, SM; Kim, TJ; Kim, YM; Kim, YT; Nam, JH; Park, JY; Seong, SJ | 1 |
| Bae, DS; Kim, DY; Kim, JH; Kim, JW; Kim, TJ; Kim, YM; Kim, YT; Lee, SH; Nam, JH; Park, JY; Seong, SJ | 1 |
| Herzog, TJ | 1 |
| Blanchard, R; Hamid, AM; Leiser, AL | 1 |
| Aoki, D; Banno, K; Nozawa, S; Susumu, N; Suzuki, A; Suzuki, N; Tamada, Y | 1 |
| Chang, CL; Chen, CP; Wang, KL; Wu, CC; Yang, YC | 1 |
| Aydiner, A; Karagol, H; Kucucuk, S; Saip, P; Topuz, E; Uygun, K | 1 |
| Denschlag, D; Gilbert, L; Kerim-Dikeni, A; Patel, S; Souhami, L; Tan, L | 1 |
| Del Priore, G; Hartzfeld, KM; Hurst, SA | 1 |
| Fjøsne, HE; Jacobsen, AB; Lundgren, S | 1 |
| Geisler, HE | 1 |
| Averette, HE; Fenton, AN; Girtanner, RW; Lichtinger, M; Lovecchio, JL; Townsend, PA | 1 |
| Dahrouge, S; Stewart, DJ | 1 |
| Beinfield, M; Fischer, D; Haffty, BG; McKhann, C; Wilmarth, L; Wilson, L | 1 |
| Brady, MF; Lentz, SS; Major, FJ; Reid, GC; Soper, JT | 1 |
| Cavanagh, D; Fiorica, JV; Hoffman, MS; Nicosia, SV; Pinelli, DM; Roberts, WS | 1 |
| Arkhipov, A; Bajetta, E; Cervek, J; di Salle, E; Dirix, LY; Dugardyn, JL; Fein, LE; Fowst, C; Jones, SE; Kaufmann, M; Massimini, G; Mennel, RG; Miller, LL; Nasurdi, C; Piscitelli, G; Polli, A; Zilembo, N | 1 |
| Larsen, M; Pors, H; Sørensen, OS; von Eyben, FE | 1 |
| Daniel, F; MacLeod, PM; Tyrrell, CJ | 1 |
| Cavanagh, D; Hoffman, MS; Lyman, GH; Praphat, H; Roberts, WS; Solomon, P | 1 |
| Creagan, ET; Ingle, JN; Schaid, DJ; Schutt, AJ | 1 |
| Badger, G; Belinson, JL; McClure, M | 1 |
| Gale, KE; Hahn, RG; Horton, J; Keller, AM; Knuiman, M; Rosenbluth, RJ; Tormey, DC; Vogel, H | 1 |
| Wentz, WB | 1 |
2 review(s) available for megestrol acetate and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Fertility-Sparing Approach in Patients with Endometrioid Endometrial Cancer Grade 2 Stage IA (FIGO): A Qualitative Systematic Review.
Topics: Adaptor Proteins, Signal Transducing; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Ki-67 Antigen; Levonorgestrel; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Recurrence, Local; NF-E2-Related Factor 2; Pregnancy; Progestins; Survivin | 2022 |
[Conservative hormonal therapy for endometrial cancer].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Antineoplastic Agents, Hormonal; Endometrial Neoplasms; Female; Humans; Hydroxyprogesterones; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Recurrence, Local; Neoplasm Staging; Treatment Outcome | 2004 |
12 trial(s) available for megestrol acetate and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Temsirolimus with or without megestrol acetate and tamoxifen for endometrial cancer: a gynecologic oncology group study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Drug Administration Schedule; Endometrial Neoplasms; Female; Humans; Immunohistochemistry; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Sirolimus; Tamoxifen | 2014 |
A Phase 2, Randomized, Open-Label Study of Irosustat Versus Megestrol Acetate in Advanced Endometrial Cancer.
Topics: Aged; Antineoplastic Agents, Hormonal; Disease-Free Survival; Endometrial Neoplasms; Female; Humans; Megestrol Acetate; Neoplasm Recurrence, Local; Receptors, Estrogen; Sulfonic Acids | 2017 |
The effect of cyproheptadine hydrochloride (periactin) and megestrol acetate (megace) on weight in children with cancer/treatment-related cachexia.
Topics: Adolescent; Adult; Appetite Stimulants; Cachexia; Child; Child, Preschool; Cyproheptadine; Female; Gastrointestinal Agents; Humans; Male; Megestrol Acetate; Neoplasm Recurrence, Local; Neoplasms; Prognosis; Quality of Life; Weight Gain | 2008 |
Reevaluating the safety of fertility-sparing hormonal therapy for early endometrial cancer.
Topics: Adult; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Chromosomes, Human, X; Endometrial Neoplasms; Estrogen Receptor alpha; Female; Fertility; Humans; Immunohistochemistry; Megestrol Acetate; Neoplasm Recurrence, Local; Ovarian Neoplasms; Prospective Studies; Receptors, Androgen; Receptors, Progesterone; Treatment Failure; X Chromosome Inactivation | 2005 |
Adjuvant cyclic Tamoxifen and Megestrol acetate treatment in postmenopausal breast cancer patients--longterm follow-up.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Follow-Up Studies; Humans; Megestrol Acetate; Middle Aged; Neoplasm Recurrence, Local; Postmenopause; Survival Analysis; Tamoxifen; Time Factors | 2008 |
Adjuvant systemic chemotherapy and hormonal therapy. Effect on local recurrence in the conservatively treated breast cancer patient.
Topics: Adult; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Female; Humans; Mastectomy, Segmental; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Recurrence, Local; Regression Analysis; Retrospective Studies; Tamoxifen | 1994 |
High-dose megestrol acetate in advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group Study.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Disease-Free Survival; Endometrial Neoplasms; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Recurrence, Local; Treatment Outcome | 1996 |
Chemotherapy plus sequential hormonal therapy for advanced and recurrent endometrial carcinoma: a phase II study.
Topics: Adult; Aged; Carboplatin; Carcinoma; Disease Progression; Drug Therapy, Combination; Endometrial Neoplasms; Female; Humans; Megestrol Acetate; Middle Aged; Neoplasm Recurrence, Local; Receptors, Estrogen; Receptors, Progesterone; Survival Analysis; Tamoxifen | 1996 |
Exemestane is superior to megestrol acetate after tamoxifen failure in postmenopausal women with advanced breast cancer: results of a phase III randomized double-blind trial. The Exemestane Study Group.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Androstadienes; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Breast Neoplasms; Disease Progression; Double-Blind Method; Female; Humans; Megestrol Acetate; Middle Aged; Neoplasm Recurrence, Local; Pain; Postmenopause; Quality of Life; Survival Analysis; Tamoxifen; Treatment Outcome | 2000 |
Megestrol acetate in relapsed carcinoma of prostate.
Topics: Carcinoma; Clinical Trials as Topic; Diethylstilbestrol; Gonadotropin-Releasing Hormone; Humans; Male; Megestrol; Megestrol Acetate; Neoplasm Recurrence, Local; Orchiectomy; Prostatic Neoplasms | 1990 |
A prospective, randomized controlled trial of megestrol acetate among high-risk patients with resected malignant melanoma.
Topics: Female; Follow-Up Studies; Humans; Male; Megestrol; Megestrol Acetate; Melanoma; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Prospective Studies; Random Allocation; Risk Factors; Time Factors; Weight Gain | 1989 |
Randomized trial of megestrol acetate vs. megestrol acetate/tamoxifen for the management of progressive or recurrent epithelial ovarian carcinoma.
Topics: Adult; Carcinoma; Clinical Trials as Topic; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Random Allocation; Tamoxifen | 1987 |
26 other study(ies) available for megestrol acetate and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Should we abandon hormonal therapy in endometrial cancer? Outcomes of recurrent and metastatic endometrial cancer treated with systemic progestins.
Topics: Antineoplastic Combined Chemotherapy Protocols; Endometrial Neoplasms; Female; Humans; Megestrol Acetate; Neoplasm Recurrence, Local; Progestins; Retrospective Studies | 2023 |
Mismatch repair status influences response to fertility-sparing treatment of endometrial cancer.
Topics: Adult; Antineoplastic Agents, Hormonal; Biomarkers; Biopsy; Disease Progression; DNA Mismatch Repair; DNA Polymerase II; Endometrial Neoplasms; Endometrium; Female; Fertility Preservation; Humans; Hysterectomy; Intrauterine Devices, Medicated; Medroxyprogesterone Acetate; Megestrol Acetate; Middle Aged; Mutation; Neoplasm Recurrence, Local; Prognosis; Receptors, Progesterone; Retrospective Studies; Tumor Suppressor Protein p53; Young Adult | 2021 |
Oncologic and obstetrical outcomes after fertility-preserving retreatment in patients with recurrent atypical endometrial hyperplasia and endometrial cancer.
Topics: Adult; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility Preservation; Gonadotropin-Releasing Hormone; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Recurrence, Local; Pregnancy; Pregnancy Outcome; Retreatment; Retrospective Studies; Young Adult | 2020 |
Continued medical treatment for persistent early endometrial cancer in young women.
Topics: Administration, Oral; Antineoplastic Agents, Hormonal; Biopsy; Carcinoma, Endometrioid; Disease-Free Survival; Drug Administration Schedule; Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Female; Fertility Preservation; Follow-Up Studies; Humans; Intrauterine Devices; Levonorgestrel; Magnetic Resonance Imaging; Medroxyprogesterone Acetate; Megestrol Acetate; Myometrium; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Prognosis; Retrospective Studies; Time Factors; Treatment Failure; Treatment Outcome; Ultrasonography | 2021 |
A successful live birth with in vitro fertilization and thawed embryo transfer after conservative treatment of recurrent endometrial cancer.
Topics: Adult; Antineoplastic Agents, Hormonal; Conservative Treatment; Cryopreservation; Embryo Transfer; Endometrial Neoplasms; Female; Fertility Preservation; Fertilization in Vitro; Humans; Letrozole; Levonorgestrel; Live Birth; Megestrol Acetate; Neoplasm Recurrence, Local; Nitriles; Pregnancy; Pregnancy Outcome; Triazoles | 2018 |
Hormone therapy following surgery in low-grade endometrial stromal sarcoma: Is it related to a decrease in recurrence rate?
Topics: Adult; Combined Modality Therapy; Endometrial Neoplasms; Female; Humans; Hysterectomy; Lymph Node Excision; Megestrol Acetate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Salpingo-oophorectomy; Sarcoma, Endometrial Stromal | 2019 |
A prospective study of fertility-sparing treatment with megestrol acetate following hysteroscopic curettage for well-differentiated endometrioid carcinoma and atypical hyperplasia in young women.
Topics: Adolescent; Adult; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Combined Modality Therapy; Curettage; Endometrial Neoplasms; Endometrium; Feasibility Studies; Female; Fertility Preservation; Humans; Hyperplasia; Hysteroscopy; Megestrol Acetate; Neoplasm Recurrence, Local; Pregnancy; Pregnancy Rate; Prospective Studies; Young Adult | 2013 |
Progestin as an alternative treatment option for multi-treated recurrent triple-negative breast cancer.
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Disease-Free Survival; Female; Humans; Kaplan-Meier Estimate; Medroxyprogesterone Acetate; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Retrospective Studies; Salvage Therapy; Treatment Outcome | 2013 |
Hormonal therapy for women with stage IA endometrial cancer of all grades.
Topics: Adenocarcinoma; Adult; Antineoplastic Agents, Hormonal; Cohort Studies; Endometrial Neoplasms; Female; Follow-Up Studies; Humans; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Recurrence, Local; Neoplasm Staging; Pregnancy; Pregnancy Outcome; Progestins; Retrospective Studies; Survival Rate; Treatment Outcome; Young Adult | 2013 |
Oncologic and reproductive outcomes after fertility-sparing management with oral progestin for women with complex endometrial hyperplasia and endometrial cancer.
Topics: Adult; Antineoplastic Agents, Hormonal; China; Disease-Free Survival; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Fertility; Fertility Preservation; Humans; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Recurrence, Local; Obesity; Pregnancy; Progestins; Recurrence; Retrospective Studies; Treatment Outcome; Young Adult | 2016 |
Clinicopathologic characteristics and treatment features of women with the incidental diagnosis of endometrial adenocarcinoma during infertility follow-up in Ankara, Turkey.
Topics: Adenocarcinoma; Adult; Antineoplastic Agents, Hormonal; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Incidental Findings; Infertility, Female; Intrauterine Devices, Medicated; Levonorgestrel; Megestrol Acetate; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Pregnancy; Pregnancy Rate; Retrospective Studies; Turkey | 2016 |
Effectiveness of high-dose progestin and long-term outcomes in young women with early-stage, well-differentiated endometrioid adenocarcinoma of uterine endometrium.
Topics: Adult; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Contraceptives, Oral, Hormonal; Female; Fertility Preservation; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Maintenance Chemotherapy; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Recurrence, Local; Retrospective Studies; Time Factors; Uterine Neoplasms; Young Adult | 2012 |
Long-term oncologic outcomes after fertility-sparing management using oral progestin for young women with endometrial cancer (KGOG 2002).
Topics: Administration, Oral; Adult; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Cohort Studies; Endometrial Neoplasms; Female; Fertility Preservation; Follow-Up Studies; Humans; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Pregnancy; Prognosis; Survival Rate; Young Adult | 2013 |
Progestin re-treatment in patients with recurrent endometrial adenocarcinoma after successful fertility-sparing management using progestin.
Topics: Adenocarcinoma; Adult; Endometrial Neoplasms; Female; Fertility Preservation; Follow-Up Studies; Humans; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Recurrence, Local; Progestins; Recurrence | 2013 |
What is the clinical value of adding tamoxifen to progestins in the treatment [correction for treament] of advanced or recurrent endometrial cancer?
Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase II as Topic; Drug Synergism; Endometrial Neoplasms; Female; Humans; Medroxyprogesterone Acetate; Megestrol Acetate; Neoplasm Recurrence, Local; Receptors, Progesterone; Tamoxifen | 2004 |
Recurrence of prolactin-producing endometrial stromal sarcoma with sex-cord stromal component treated with progestin and aromatase inhibitor.
Topics: Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Endometrial Neoplasms; Enzyme Inhibitors; Female; Humans; Megestrol Acetate; Middle Aged; Neoplasm Recurrence, Local; Nitriles; Progestins; Prolactin; Sarcoma, Endometrial Stromal; Triazoles | 2004 |
Evaluation of prognostic factors and comparison of systemic treatment modalities in patients with recurrent or metastatic endometrial carcinoma.
Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Cyclophosphamide; Doxorubicin; Endometrial Neoplasms; Female; Humans; Medroxyprogesterone Acetate; Megestrol Acetate; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Hormone-Dependent; Paclitaxel; Prognosis; Retrospective Studies; Survival Analysis; Treatment Outcome | 2006 |
Stage III endometrial cancer: preoperative predictability, prognostic factors, and treatment outcome.
Topics: Adnexa Uteri; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; CA-125 Antigen; Canada; Carcinoma; Chemotherapy, Adjuvant; Cystadenoma, Serous; Endometrial Neoplasms; Fallopian Tubes; Female; Humans; Hysterectomy; Lymph Node Excision; Megestrol Acetate; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Ovariectomy; Prognosis; Radiotherapy, Adjuvant; Registries | 2007 |
Occult myometrial recurrence after progesterone therapy to preserve fertility in a young patient with endometrial cancer.
Topics: Adenocarcinoma; Adult; Antineoplastic Agents, Hormonal; Dilatation and Curettage; Endometrial Neoplasms; Female; Fertility; Humans; Hysterectomy, Vaginal; Hysteroscopy; Infertility, Female; Laparoscopy; Magnetic Resonance Imaging; Megestrol Acetate; Myometrium; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Ovariectomy; Pregnancy; Progestins; Quality of Life; Reproductive Techniques, Assisted; Surrogate Mothers; Treatment Outcome | 2008 |
Megestrol acetate for the palliation of advanced ovarian carcinoma.
Topics: Administration, Oral; Adolescent; Adult; Aged; Cystadenocarcinoma; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Palliative Care; Time Factors | 1983 |
Treatment of advanced or recurrent endometrial adenocarcinoma with cyclophosphamide, doxorubicin, cis-Platinum, and megestrol acetate.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Doxorubicin; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Recurrence, Local; Uterine Neoplasms | 1984 |
Response of brain metastases from breast cancer to megestrol acetate: a case report.
Topics: Adenocarcinoma; Antineoplastic Agents; Breast Neoplasms; Cerebellar Neoplasms; Combined Modality Therapy; Disease Progression; Fatal Outcome; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Recurrence, Local | 1995 |
Longterm remission of multiple brain metastases with tamoxifen.
Topics: Activities of Daily Living; Aged; Antineoplastic Agents; Brain Neoplasms; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Combined Modality Therapy; Estrogens; Female; Humans; Mastectomy, Radical; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Neoplasm Recurrence, Local; Neoplasms, Hormone-Dependent; Palliative Care; Psychomotor Disorders; Tamoxifen | 1991 |
Treatment of recurrent and metastatic endometrial cancer with cisplatin, doxorubicin, cyclophosphamide, and megestrol acetate.
Topics: Aclarubicin; Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Female; Humans; Megestrol; Megestrol Acetate; Neoplasm Recurrence, Local; Peplomycin; Uterine Neoplasms | 1989 |
Combination hormone therapy for metastatic breast cancer. An ECOG study of megestrol and aminoglutethimide.
Topics: Adult; Aged; Aged, 80 and over; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Hydrocortisone; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local | 1987 |
Progestin therapy in lesions of the endometrium.
Topics: Adenocarcinoma; Adult; Endometrial Hyperplasia; Female; Humans; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Recurrence, Local; Uterine Neoplasms | 1985 |